CAS: 151077-62-2 - N-(2-(3-(trifluoromethyl)diazirin-3-yl)phenyl)-4-maleimidobutyramide
Formula:C16H13F3N4O3
InChI:InChI=1/C16H13F3N4O3/c17-16(18,19)15(21-22-15)10-3-1-4-11(9-10)20-12(24)5-2-8-23-13(25)6-7-14(23)26/h1,3-4,6-7,9H,2,5,8H2,(H,20,24)
- Sinonimi:
- N-(m-(3-(Trifluoromethyl)-diazirin-3-yl)phenyl)-4-maleimidobutyramide
- Tdpmb
- 1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-(3-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)-
- 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{3-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}butanamide
1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-
CAS:151077-62-2
Formula:
C16H13F3N4O3
Peso molecolare:
366.2946
Ref: IN-DA001N2F
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 03 Dicembre 2024
2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide
CAS:151077-62-2
2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide (LZP) is an experimental drug that inhibits the growth of cancer cells. It has …
Formula:
C16H13F3N4O3
Purezza:
Min. 95%
Peso molecolare:
366.29 g/mol
Ref: 3D-FD102184
Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Giovedì 12 Dicembre 2024